Hamid Reza Heidari

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 4

Top Topics

Locally Advanced

Top Venues

Advanced pharmaceutical bulletin

Medical oncology (Northwood, London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Morteza Golbashirzadeh, Hamid Reza Heidari, Ali Asghar Aghamolayi, Yasin Fattahi, Mehdi Talebi, Ahmad Yari Khosroushahi
In vitro siRNA-mediated GPX4 and AKT1 silencing in oxaliplatin resistance cancer cells induces ferroptosis and apoptosis. Medical oncology (Northwood, London, England) 40 (10) (2023)
Morteza Golbashirzadeh, Hamid Reza Heidari, Mehdi Talebi, Ahmad Yari Khosroushahi
Ferroptosis as a Potential Cell Death Mechanism Against Cisplatin-Resistant Lung Cancer Cell Line. Advanced pharmaceutical bulletin 13 (1) (2021)
Morteza Golbashirzadeh, Hamid Reza Heidari, Mehdi Talebi, Ahmad Yari Khosroushahi
Ferroptosis as a Potential Cell Death Mechanism Against Cisplatin-Resistant Lung Cancer Cell Line. Advanced pharmaceutical bulletin 13 (1) (2021)
Yunes Panahi, Ahmad Yari Khosroushahi, Amir Hossein Sahebkar, Hamid Reza Heidari
Impact of Cultivation Condition and Media Content onChlorella vulgaris Composition. Advanced pharmaceutical bulletin 9 (2) (2019)